Piecan Pharma Profile
Key Indicators
- Authorised Capital ₹ 4.50 M
- Paid Up Capital ₹ 4.50 M
- Company Age 8 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.29 Cr
- Revenue Growth -19.77%
- Profit Growth -172.92%
- Ebitda 91.44%
- Net Worth -1.04%
- Total Assets 3.29%
About Piecan Pharma
Piecan Pharma Private Limited (PPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 31 May 2016 (Eight years and eight months 7 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.50 M and a paid-up capital of Rs 4.50 M.
The company currently has active open charges totaling ₹1.29 Cr.
Nareshkumar Dhanvania and Rahulkumar Makvana serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24299GJ2016PTC092261
-
Company No.
092261
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
31 May 2016
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Piecan Pharma Private Limited offer?
Piecan Pharma Private Limited offers a wide range of products and services, including Homeopathic Medicines & Remedies, Homeopathic Drugs, Hand Sanitizers & Personal Hygiene, Hand Sanitizer & Disinfectant, Ayurvedic,Herbal Products & Medicine, Ayurvedic Herbal Syrups & Tonics, Ayurvedic Medicine, Ayurvedic Immunity Booster, Cough Syrup, Vitamin Tablets & Capsules.
Who are the key members and board of directors at Piecan Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nareshkumar Dhanvania
|
Director | 31-May-2016 | Current |
|
Rahulkumar Makvana
|
Additional Director | 21-Jun-2024 | Current |
Financial Performance of Piecan Pharma.
Piecan Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 19.77% decrease. The company also saw a substantial fall in profitability, with a 172.92% decrease in profit. The company's net worth dipped by a decrease of 1.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Piecan Pharma?
Unlock access to Piecan Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Kapasi Pharma Private LimitedNareshkumar Dhanvania is a mutual person
Charges (Loans)
₹12.90 M
₹0
Charges Breakdown by Lending Institutions
- The South Indian Bank Limited : 1.29 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Jun 2017 | The South Indian Bank Limited | ₹1.29 Cr | Open |
How Many Employees Work at Piecan Pharma?
Unlock and access historical data on people associated with Piecan Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Piecan Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Piecan Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
